Stanford University
Showing 31,801-31,850 of 37,018 Results
-
Azusa Terasaki
Postdoctoral Scholar, Pathology
BioAzusa Terasaki, MD, PhD, is a Postdoctoral scholar in the Department of Pathology at Stanford University School of Medicine. Her research focuses on tumor immunology and cancer metabolism, with a particular interest in mitochondrial transfer between cancer and immune cells and its role in immune suppression and metastasis.
Dr. Terasaki received her medical degree and PhD in Japan, where she completed her surgical training and is a board-certified surgeon with additional certifications as a breast specialist and in cancer therapy. During her clinical career, she developed a strong interest in translational research that bridges fundamental discoveries and patient care.
Her current work investigates how cancer cells reprogram immune cells through organelle transfer, integrating imaging, flow cytometry, and multi-omic approaches to uncover novel mechanisms of tumor–immune interaction. Her goal is to identify new therapeutic targets and biomarkers to improve cancer treatment outcomes. -
Maximilian Terhalle
Visiting Scholar,
Affiliate, FinanceBioDr Maximilian Terhalle is currently a visiting scholar at Stanford University's Hoover Institution, an appointment that follows his attendance of Hoover's International Seminar in 2023. In his home country, he serves as an instructor at the Hamburg-based Defence Academy (Germany).
Thinking "fast and slow" about the art of making strategic choices, about strategies and strategic culture lies at the heart of his research, shaped as it is by real-world practice. A former strategic adviser himself (UK MoD), Maximilian aims at weaving together notions of common sense, insights from neuroscience, political psychology, historical knowledge, as well as notions of leadership into his understanding of strategic mindsets, grand strategy and national security.
At Stanford/Hoover, Maximilian looks forward to pushing the boundaries of his own understanding of the latest round in the "struggle for power" which the West is undergoing in world politics.
Previously, he taught and/or conducted research at Columbia's SIPA , Yale, LSE, Oxford, and King's College London, among others. His most recent book is "The Responsibility to Defend: Re-thinking Germany's Strategic Culture" (IISS 2021, w. Bastian Giegerich).
He obtained his Master's degrees from London and Bonn Universities (1998, 2005), his PhD from Bonn University (GER, 2006) and his Habilitation (higher doctorate) from Potsdam University (GER, 2016). Also, Maximilian is a reserve officer, currently holding the rank of a lieutenant colonel (reconn.). He is married with four amazing children. -
Nele Marie Terveen
Affiliate, Geballe Laboratory for Advanced Materials
BioNele Marie Terveen is an Assistant Professor (Lecturer) in Innovation & Strategy at the University of Auckland, New Zealand, and is affiliated with Stanford in Professor Yi Cui's lab.
In her research, she looks at complex problems, serendipity, and innovation as well as ideation processes, specifically in the sustainability domain. She loves to explore novel phenomena through inductive and ethnographic study designs.
She aims to drive transformation at the intersection of science and practice, was invited to speak in the European Parliament for the Green Pioneers, is involved as a Fellow in the Think Tank of the Club of Rome Germany, and serves as a jury member of the Green Startup Program of the Deutsche Bundesstiftung Umwelt, as well as an ambassador of the Economy for the Common Good. -
Jeffrey Teuteberg
Professor of Medicine (Cardiovascular Medicine)
On Leave from 12/15/2025 To 12/14/2027BioHe is currently a Professor of Medicine at Stanford, but is no longer seeing patients as he is on leave and working with industry.
His research interests are in clinical outcomes in patients after transplant and mechanical support as well as novel approaches to immunosuppression. He has participated in many single-center and multi-institutional research studies and has published widely in the fields of transplant and mechanical support. He served as President of the International Society of Heart and Lung Transplantation in 2018. -
Winifred Teuteberg
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Teuteberg completed residency training in Internal Medicine at the University of Chicago and a Palliative Medicine Fellowship at Massachusetts General Hospital. She joined the faculty at Stanford in 2017 and currently sees patients as a part of the inpatient palliative care consult team at Stanford Healthcare.
She has been the clinical director or Stanford Medicine's implementation of the Ariadne Labs' Serious Illness Care Program since its inception in 2018. Her interests include communication skills training, leveraging predictive algorithms to identify patients who would most benefit from serious illness conversations, how to empower non-physician clinical team members to participate in this work, and best practice for EHR builds related to advance care planning. -
Haluk Tezcan, MD
Adjunct Clinical Associate Professor, Medicine - Oncology
BioClinical focus:
Breast Oncology
Molecular Diagnostics
Dr. Tezcan is a medical oncologist and hematologist with over three decades of diverse experience in cancer management and research.
He is leading the clinical development of Droplet Biosciences' novel liquid biopsy technology, a first-in-class lymphatic fluid molecular residual disease assessment, overseeing the scientific and clinical development of the technology. With over three decades of direct patient care and clinical trial experience as a principal investigator and director, both in academia and private practice, he has a firsthand understanding of the unmet clinical needs of physicians and patients, as well as broad experience in clinical trial design and implementation.
He is also co-principal at Athea Oncology, guiding practices and hospitals in developing clinical trial programs and high-value real-world data collection and diagnostic companies in clinical development. He is also a reviewer of JCO Precision Medicine.
Before joining Athea Oncology and Droplet Biosciences, he was the co-founder of LexentBio, which was successfully acquired by Roche/FMI. He also served as Director of Translational Medicine at Genomic Health and as Vice President, leading oncology development at Counsyl, where he integrated science with clinical product development. He established the CA.RE.foundation, a cancer research foundation dedicated to enabling the execution of clinical trials across community oncology sites throughout the Northwest US. He has independently built multiple software tools to help oncologists navigate the practical realities of their daily work.
